Stay updated on Lebrikizumab in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Lebrikizumab in Atopic Dermatitis Clinical Trial page.
Latest updates to the Lebrikizumab in Atopic Dermatitis Clinical Trial page
- Check4 days agoChange DetectedThe website has been updated from version v2.10.2 to v2.10.3.SummaryDifference0.0%
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.0%
- Check32 days agoNo Change Detected
- Check47 days agoChange DetectedThe website has been updated to version v2.10.0, adding two more study numbers and indicating that the study now has 94 locations, while the previous version v2.9.7 has been removed.SummaryDifference0.2%
- Check54 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.0%
- Check68 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the version of the web page content.SummaryDifference0.0%
- Check73 days agoChange DetectedThe value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the version of the web page content.SummaryDifference0.0%
Stay in the know with updates to Lebrikizumab in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lebrikizumab in Atopic Dermatitis Clinical Trial page.